Abstract
Matrix metalloproteinases (MMPs) are a family of zinc endopeptidases, regulated by endogenous tissue inhibitors (TIMPs) and inducer (EMMPRIN). The demonstration of a functional role of MMPs in pulmonary diseases raises the possibility of therapeutic intervention targeting MMP/TIMP balance to prevent pathological processes.
Keywords: Pulmonary diseases, MMP, TIMP, EMMPRIN, regulation
Letters in Drug Design & Discovery
Title: Regulation of MMP/TIMP Balance as Therapeutic Target in Pulmonary Diseases
Volume: 3 Issue: 3
Author(s): Corinne A.E. Martin-Chouly, Stephanie Guillot, Stephane Jouneau, Sylvie Caulet-Maugendre, Laurent Vernhet, Vincent Lagente and Philippe Delaval
Affiliation:
Keywords: Pulmonary diseases, MMP, TIMP, EMMPRIN, regulation
Abstract: Matrix metalloproteinases (MMPs) are a family of zinc endopeptidases, regulated by endogenous tissue inhibitors (TIMPs) and inducer (EMMPRIN). The demonstration of a functional role of MMPs in pulmonary diseases raises the possibility of therapeutic intervention targeting MMP/TIMP balance to prevent pathological processes.
Export Options
About this article
Cite this article as:
Martin-Chouly A.E. Corinne, Guillot Stephanie, Jouneau Stephane, Caulet-Maugendre Sylvie, Vernhet Laurent, Lagente Vincent and Delaval Philippe, Regulation of MMP/TIMP Balance as Therapeutic Target in Pulmonary Diseases, Letters in Drug Design & Discovery 2006; 3 (3) . https://dx.doi.org/10.2174/157018006776287005
DOI https://dx.doi.org/10.2174/157018006776287005 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers